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Problem
Volume depletion is the mainstay of treatment for acute heart failure, mainly with loop diuretics such as furosemide. However, some patients develop resistance to diuretics. Among the alternatives that have arisen as a potential solution to this clinical problem is the use of hypertonic saline. The increase in plasma osmolarity allows mobilization of extracellular fluid into intravascular. As baroceptors sense intravascular expansion, peripheral resistance decreases, improving ejection fraction, therefore increasing kidney and other organs blood flow, which improves response to diuretics. In addition, animal studies show hypertonic saline alone could improve myocardial contractility and reduce proinflammatory factors.
Methods
We used Epistemonikos database, which is maintained by screening more than 30 databases, to identify systematic reviews and their included primary studies. With this information we generated a structured summary using a pre-established format, which includes key messages, a summary of the body of evidence (presented as an evidence matrix in Epistemonikos), meta-analysis of the total of studies, a summary of findings table following the GRADE approach and a table of other considerations for decision-making.
Key messages
 Adding hypertonic saline to furosemide probably decreases mortality, length of hospital stay and hospital readmissions in patients with acute heart failure.
About the body of evidence for this question
What is the evidence.
See evidence matrix in Epistemonikos later
We found two systematic reviews [1] , [2] including nine randomized controlled trials reported in 10 references [3] , [4] All studies compared with furosemide alone that was administered in the same way and dose as in the group intervened.
What types of outcomes were measured
All-cause mortality, mortality from heart failure, need for hospitalization, length of hospital stay, change in New York Heart Association (NYHA) classification, renal function, cardiac markers, body weight.
Summary of findings
Information on the effects of adding hypertonic saline to the treatment with furosemide is based on nine randomized trials including 2566 patients. Only four studies reported overall mortality [4]  Adding hypertonic saline to furosemide probably decreases mortality in patients with acute heart failure. The certainty of the evidence is moderate.
 Adding hypertonic saline to furosemide probably decreases length of hospital stay in patients with acute heart failure. The certainty of the evidence is moderate.
 Adding hypertonic saline to furosemide probably decreases hospital readmissions in patients with acute heart failure. The certainty of the evidence is moderate. doi: 10.5867/medwave.2015.6233
Other considerations for decision-making
To whom this evidence does and does not apply  The studies coincide on including patients with decompensated heart failure from any cause with decreased ejection fraction (EF <45%) with serum creatinine lower than 2 mg/dl, so the main population to apply this treatment are patients with these characteristics .
 While studies excluded patients with creatinine greater than 2, it is reasonable to extrapolate this evidence to patients with severe renal dysfunction as pathophysiology would suggest a similar or greater effect.
About the outcomes included in this summary
 The outcomes presented in this summary are those considered critical for decision making by the authors of this summary, and coincide with those used in major clinical guidelines [13] , [14] , [15] , [16] .
Balance between benefits and risks, and certainty of the evidence  The use of hypertonic saline with furosemide is a low-cost therapy that could decrease the use of inotropic therapy, mortality, hospital readmission, length of hospital stay and plasma creatinine (creatinine decreased in 0.56 mg/dl in the hypertonic saline group).
Resource considerations
 Regarding resources, it is considered a low-cost intervention, so the cost/benefit ratio is favorable.
Differences between this summary and other sources
 Our conclusions are consistent with those of the systematic reviews [1] , [2] in terms of mortality reduction, readmission, length of hospital stay and decreased plasma creatinine.
 None of the main clinical guidelines [13] , [14] , [15] , [16] mentioned the addition of hypertonic saline to furosemide, although it is important to state the systematic reviews were published later than most guidelines. Could this evidence change in the future?
 The likelihood that future evidence change the information presented in this summary is low due to the certainty of the evidence.
 We did not identify additional ongoing studies, so it is unlikely that new relevant information to this question appears. doi: 10.5867/medwave.2015.6233
How we conducted this summary
Using automated and collaborative means, we compiled all the relevant evidence for the question of interest and we present it as a matrix of evidence.
Follow the link to access the interactive version: Hypertonic saline plus furosemide for acute heart failure
Notes
The upper portion of the matrix of evidence will display a warning of "new evidence" if new systematic reviews are published after the publication of this summary. Even though the project considers the periodical update of these summaries, users are invited to comment in Medwave or to contact the authors through email if they find new evidence and the summary should be updated earlier. After creating an account in Epistemonikos, users will be able to save the matrixes and to receive automated notifications any time new evidence potentially relevant for the question appears.
The details about the methods used to produce these summaries are described here http://dx.doi.org/10.5867/medwave.2014.06.5997.
Epistemonikos foundation is a non-for-profit organization aiming to bring information closer to health decisionmakers with technology. Its main development is Epistemonikos database (www.epistemonikos.org).
These summaries follow a rigorous process of internal peer review. 
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